Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Viral Recombination

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Viruses with RNA Genomes

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...

Global Regulatory Systems

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Chavda et al. Peptide-Drug Conjugates: A New Hope for Cancer Management. <i>Molecules</i> 2022, <i>27</i>, 7232.

Molecules (Basel, Switzerland)·2025

Same author

Control measures for neglected tropical diseases: vaccine updates.

Expert review of vaccines·2025

Same author

Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. <i>Molecules</i> 2022, <i>27</i>, 4315.

Molecules (Basel, Switzerland)·2025

Same author

Proinflammatory Cytokines in Chronic Respiratory Diseases and Their Management.

Cells·2025

Same author

Inflammation: The Cause of All Diseases.

Cells·2024

Same author

Unveiling the promise: Exosomes as game-changers in anti-infective therapy.

Exploration (Beijing, China)·2024

Search research articles

Related Experiment Video

Updated: Sep 30, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

SARS-CoV-2 variants and vulnerability at the global level.

Vivek P Chavda¹, Aayushi B Patel², Darsh D Vaghasiya²

¹Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Ahmedabad, Gujarat, India.

Journal of Medical Virology

|March 12, 2022

Summary

New severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants pose risks to COVID-19 vaccine immunity. Understanding these evolving SARS-CoV-2 variants is crucial for public health strategies.

Keywords:

Delta plus variant Delta variant Omicron variant SARS-CoV-2 mutation vaccination viral variant

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

Related Experiment Videos

Last Updated: Sep 30, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Quantification and Whole Genome Characterization of SARS-CoV-2 RNA in Wastewater and Air Samples

Published on: June 30, 2023

Area of Science:

Virology
Immunology
Public Health

Background:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved numerous variants.
These variants can evade immunity from existing COVID-19 vaccinations.
Variants exhibit increased transmissibility, severity, immune evasion, and reinfection susceptibility.

Purpose of the Study:

To review and summarize the emergence of various SARS-CoV-2 variants.
To focus on variants of concern (VOCs) globally circulating.
To analyze the impact of viral mutations on virus properties.

Main Methods:

Literature review of scientific publications and reports.
Analysis of data on SARS-CoV-2 variant characteristics.
Categorization of variants by health organizations like the CDC.

Main Results:

Several variants of concern (VOCs) and variants of interest (VOIs) have been identified.
Mutations in SARS-CoV-2 alter its transmissibility, virulence, and immunogenicity.
Antibody neutralization by vaccinated individuals is decreased by certain variants.

Conclusions:

Continuous monitoring of SARS-CoV-2 variants is essential.
Understanding variant evolution is critical for vaccine efficacy and public health.
The study highlights the dynamic nature of the pandemic and the need for adaptive strategies.